ุทูุงุจ ุงูุฎุงู
ุณุฉ
ุงูุง ุงู ุดุงุก ุงููู ุงูู ู ุงููุงูุณุฑ ูุงุจุฏู ุจุงูููุณูุฉ
ู ูุง ูุฐุงู ุงูููุช ููุงู ุทูุงุจ ุชุฑูุฏ ู ูุงุฒู ู ุฑุชุจุฉ ููููุณูุฉ
ู ุงู ุดุงุก ุงููู ุงุซูุงุก ุดุฑุญู ูููุงูุณุฑ
ุฑุญ ุชูุฒู ุจููุฉ ุงูู ูุงุถูุน ุจุดูู ู ูุงุฒู ู ุฑุชุจุฉ ุชุจุงุนุง
ุงูุง ุงู ุดุงุก ุงููู ุงูู ู ุงููุงูุณุฑ ูุงุจุฏู ุจุงูููุณูุฉ
ู ูุง ูุฐุงู ุงูููุช ููุงู ุทูุงุจ ุชุฑูุฏ ู ูุงุฒู ู ุฑุชุจุฉ ููููุณูุฉ
ู ุงู ุดุงุก ุงููู ุงุซูุงุก ุดุฑุญู ูููุงูุณุฑ
ุฑุญ ุชูุฒู ุจููุฉ ุงูู ูุงุถูุน ุจุดูู ู ูุงุฒู ู ุฑุชุจุฉ ุชุจุงุนุง
โค38๐3๐ฏ2
Alzheimer Disease.pdf
2.7 MB
โค23๐ฏ3
A 66 years old woman is suffering from low mineral bone density and strong family history of breast cancer.
What would be the best protective agent? #Breast_Cancer
What would be the best protective agent? #Breast_Cancer
Anonymous Quiz
34%
a- Tamoxifen
50%
b- Raloxifene
8%
c-Exemestane
6%
d- Cyclophosphamide
2%
e- None of them
โค5
A 41 years old woman with a positive family history of breast cancer.
What is the treatment of choice to reduce her risk breast cancer risk?
What is the treatment of choice to reduce her risk breast cancer risk?
Anonymous Quiz
15%
a- Raloxifen
6%
b- Letrozole
53%
c- Tamoxifen
1%
d- Exemestane
25%
e- B and D
โค3
๐๐ฅ๐ข๐ก ๐ฆ๐ง๐จ๐๐ฌ
#Breast_Cancer
Drug used to prevent Breast cancer.
Which drug increased incidence of endometrial cancer
a- Exemestane
b- anastrozole
c- tamoxifen
d- raloxifene
e- Letrozole
ูุฒุงุฑู ุฏูุฑ ุงูู 2024
ุงูุญู ู ู ุงูุตูุฑุฉ ๐ซ
#Breast_Cancer
Which drug increased incidence of endometrial cancer
a- Exemestane
b- anastrozole
c- tamoxifen
d- raloxifene
e- Letrozole
ูุฒุงุฑู ุฏูุฑ ุงูู 2024
ุงูุญู ู ู ุงูุตูุฑุฉ ๐ซ
#Breast_Cancer
โค8๐1
Which genetic mutations significantly incrcase the lifetime risk of breast cancer?
a- BRCA1 and BRCA2
b- TPS3 and EGFR
c- KRAS and NRAS
d- ATM and CHEK2
e- BRCA3 and PALB2
ุฏูุฑ ุงูู 2024
ุทุจุนุง ูุงู ุงูุงุณุฆูุฉ ุชุฎุต ุงูู ู ุญุงุถุฑุฉ ูุฒูุชูุง ุงููู
ุงูู ุญุงุถุฑุฉ ุงูุฌุงูุฉ ุนูุงุฌุงุช ุงู breast cancer
ุณุคุงู ุณูู ูุญุชู ู ุชูุณูู Breast Cancer ูู BR CA
#Breast_Cancer
a- BRCA1 and BRCA2
b- TPS3 and EGFR
c- KRAS and NRAS
d- ATM and CHEK2
e- BRCA3 and PALB2
ุฏูุฑ ุงูู 2024
ุทุจุนุง ูุงู ุงูุงุณุฆูุฉ ุชุฎุต ุงูู ู ุญุงุถุฑุฉ ูุฒูุชูุง ุงููู
ุงูู ุญุงุถุฑุฉ ุงูุฌุงูุฉ ุนูุงุฌุงุช ุงู breast cancer
ุณุคุงู ุณูู ูุญุชู ู ุชูุณูู Breast Cancer ูู BR CA
#Breast_Cancer
โค7
Salma is a 35 years old women presented to gynecologist seeking for strategies for breast cancer prevention because of her positive family history with BRCA 1 and BRCA2 gene test; The best treatment for risk reduction include:
Anonymous Quiz
13%
A) Breast conserving surgery
58%
B) Tamoxifen taken for 5 years
16%
C) Anstrazole taken for 5 years
2%
D) No prevention is needed
11%
E) Life style modification only
โค4
45-year-old patient with HER2+ breast cancer received neoadjuvant chemotherapy plus trastuzumab and pertuzumab.
At surgery, a residual disease was found. Which agent is most appropriate for adjuvant therapy in this condition ?
At surgery, a residual disease was found. Which agent is most appropriate for adjuvant therapy in this condition ?
Anonymous Quiz
6%
A) Continue trastuzumab alone
3%
B) Lapatinib
10%
C) Neratinib
77%
D) Ado-trastuzumab emtansine (TDM1)
4%
E) Tucatinib
โค7
Forwarded from Mcq 4th and 5th stage
ุงู
ุณููู ู
ุฑุญูุฉ ุฎุงู
ุณุฉ ููุฑุณ ุซุงูู
ู ูุงุฏ ุงููุธุฑู
ุนูุงุฌูุงุช
ุงุฏูุงูุณ
ุงูุชุตุงุฏูุงุช.
TDM
DDS
ุงูุจุงููุชููููุฌู
ู /// ู ู ููุฒู ุดู ููุถุงู ุน ุงูููุงุฆู ุญุณุจ ูู ู ุงุฏุฉ๐
ู ูุงุฏ ุงููุธุฑู
ุนูุงุฌูุงุช
ุงุฏูุงูุณ
ุงูุชุตุงุฏูุงุช.
TDM
DDS
ุงูุจุงููุชููููุฌู
ู /// ู ู ููุฒู ุดู ููุถุงู ุน ุงูููุงุฆู ุญุณุจ ูู ู ุงุฏุฉ๐
โค6
๐2โค1
A patient with HER2-positive MBC was initially treated with a combination of pertuzumab, trastuzumab, and a taxane.
After months, her disease progressed. Which of the following treatments is most appropriate as second-line HER2- targeted therapy?
After months, her disease progressed. Which of the following treatments is most appropriate as second-line HER2- targeted therapy?
Anonymous Quiz
65%
A) Ado-trastuzumab emtansine (TDM1)
4%
B) Imatinib
11%
C) Neratinib
9%
D) Tamoxifen
12%
E) Fulvestrant
HER2 over expressing MBC, what is the preferred First line therapy?
Anonymous Quiz
2%
A) carboplatin - gemcitabine
85%
B) pertuzumab-trastuzumab- taxane
5%
C) everolimus - tamoxifen
5%
D) talazoparib-famtrastuzumab
2%
E) doxorubicin - docetaxel